Generic Pharmaceuticals Company Investment Opportunity in Davie, United States
| Established | 5-10 year(s) |
| Employees | 2 - 5 |
| Legal Entity | C Corporation |
| Reported Sales | USD 594 thousand |
| Run Rate Sales | USD 504 thousand |
| EBITDA Margin | 40 % |
| Industries | Generic Pharmaceuticals |
| Locations | Davie |
| Local Time | 1:51 AM America / Nipigon |
| Listed By | Business Owner / Director |
| Status | Active |
Currently have 6 OTC topical products in the product portfolio, with an expected 1 additional OTC cream to launch by this year. Product sales are currently generated through Amazon and Walmart listings. We have been growing at 8-10 percent annually.
Lidocaine topical pain creams (4% and 5% strengths).
Clotrimazole topical antifungal cream.
Diclofenac Sodium topical arthritis gel.
Homogenizer mixer.
Tube filler.
Packaging conveyor.
Scales.
Weights.
Power transformers.
Compressor.
4,000 square feet, separated office spaces with a dedicated manufacturing room, primary and secondary packaging.
Business's current balances on the following liabilities are:
Amazon Lending 70K.
Marcus by Goldman 50K.
Finstart 36K.
Discover 20K.
Total number of shareholders is 5, with 3 expressing interest in a buyout totaling 205K.
-
Earlier than 15 daysPresident, Dental Clinics, Winnipeg, Corporate Investor / Buyer connected with the Business
-
Earlier than 15 daysDirector, Pharmacy, Hatfield, Individual Investor / Buyer connected with the Business
-
Earlier than 15 daysCEO, Healthcare, Dublin, Individual Investor / Buyer connected with the Business
Generic Pharmaceuticals Company Investment Opportunity in Davie, United States
·Invest in Generic Pharmaceuticals Company in Davie, United States
·Generic Pharmaceuticals Company Investment Opportunity
·Investment Opportunity in Davie, United States
·Invest in Generic Pharmaceuticals Company
·Invest in Davie, United States
26 Investors viewed this Business this month.
Register below to connect now!
- Social
- Register
- Login
